ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
中国生物制药ADR
15.89
0.0000
成交量：
- -
成交额：
- -
市值：
144.64亿
市盈率：
30.32
高：
15.89
开：
15.89
低：
15.89
收：
15.89
52周最高：
20.16
52周最低：
8.76
股本：
9.10亿
流通股本：
4.58亿
量比：
0.70
换手率：
- -
股息：
0.24
股息率：
1.51%
每股收益(TTM):
0.5241
每股收益(LYR):
0.5242
净资产收益率：
15.40%
总资产收益率：
5.07%
市净率：
2.99
市盈率(LYR):
30.31
数据加载中...
总览
公司
新闻资讯
公告
正大天晴与赛诺菲达成超15亿独家授权；诺和诺德MASH新适应症拟纳入优先审评；全球首款宫颈癌前病变无创治疗药物获批上市
药财社
·
03/05
中国生物制药：集团自主研发的1类创新药罗伐昔替尼上市获得药监局上市批准
财经网
·
03/02
同类首创引领骨髓纤维化治疗新时代，正大天晴罗伐昔替尼获批上市
CPHI制药在线
·
03/02
【券商聚焦】中泰国际指港股受地缘政治影响，科技与资源股表现分化
金吾财讯
·
02/24
政府伙29间大型企业 为香港青年提供海内外暑期实习机会
阿斯达克财经
·
02/12
港股指数早盘冲高回落 恒指半日升0.54 受压居前 新东方(09901)跌4.71%
金吾财讯
·
02/10
医药生物行业周报：并购与授权合作持续活跃，关注创新药领域资源整合加速
上海证券
·
01/27
中国生物制药慢乙肝1类新药Ⅱ期临床达主要终点，为低病毒血症提供新方案
正大制药订阅号
·
01/27
25年恒指累涨近28%：中国宏桥暴涨203.72%居成份股榜首，近10只个股翻倍
格隆汇
·
2025/12/31
中国生物制药获副总裁兼执行董事谢炘增持100万股 每股作价约6.41港元
新浪网
·
2025/12/25
18款1类新药首次获批临床！中国生物制药2025年多领域创新破局，全球化研发体系再深化
正大制药订阅号
·
2025/12/25
热搜第一！“进口抗癌假药”1500元一盒，有效成分却为0
中国基金报
·
2025/12/22
【券商聚焦】中州国际指恒指短期承压，关注医药及能源板块
金吾财讯
·
2025/12/10
脱发新药III期成功；创新药出海新模式诞生
药创新
·
2025/12/06
利好密集来袭！创新药概念大爆发
东方财富研究中心
·
2025/10/31
2025年西药行业市场发展现状趋势分析
中研网
·
2025/10/31
中国生物制药又一款 1 类新药首次启动临床
丁香园 Insight 数据库
·
2025/10/30
中国生物制药(1177HK)：PDE3/4抑制剂II期临床数据亮眼 市场潜力巨大
招银国际
·
2025/10/13
大健康行业周报 |13亿，“中国美敦力”完成交割；东星医疗：拟以支付现金方式购买武汉医佳宝90%的股权
保观
·
2025/09/29
华源证券-医药行业周报信立泰：全面布局CKM管线，创新出海加速推进-250928
新浪财经
·
2025/09/28
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SBHMY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SBHMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBHMY\",,,,,undefined,":{"symbol":"SBHMY","market":"US","secType":"STK","nameCN":"中国生物制药ADR","latestPrice":15.89,"timestamp":1774036800000,"preClose":15.89,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":457950931,"shares":910273459,"eps":0.524054,"marketStatus":"休市中","change":0,"latestTime":"03-20 16:00:00 EDT 延时","open":15.89,"high":15.89,"low":15.89,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.524054,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":20,"exchange":"PINK LIMITED","adjPreClose":15.89,"volumeRatio":0.7024825319453931},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBHMY\",,,,,undefined,":{"symbol":"SBHMY","floatShares":457950931,"roa":"5.07%","roe":"15.40%","lyrEps":0.524215,"volumeRatio":0.7024825319453931,"shares":910273459,"dividePrice":0.240325,"high":15.89,"amplitude":0,"preClose":15.89,"low":15.89,"week52Low":8.755,"pbRate":"2.99","psRate":"3.27","week52High":20.16,"institutionHeld":0,"latestPrice":15.89,"eps":0.524054,"divideRate":0.015124,"volume":0,"delay":15,"ttmEps":0.524054,"open":15.89,"prevYearClose":18.22,"prevWeekClose":15.89,"prevMonthClose":15.89,"prevQuarterClose":18.22,"fiveDayClose":15.89,"twentyDayClose":15.89,"sixtyDayClose":18.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBHMY\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"SBHMY","amount":0.127855,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-29","defaultRemindTime":1756474200000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-08","payableDate":"2025-08-29","currency":"USD","dateTimestamp":1756440000000,"payDate":"2025-10-08"},{"date":"2025-06-17","symbol":"SBHMY","amount":0.102066,"announcedDate":"2025-05-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-17","defaultRemindTime":1750167000000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-25","payableDate":"2025-06-17","currency":"USD","dateTimestamp":1750132800000,"payDate":"2025-07-25"},{"date":"2024-09-12","symbol":"SBHMY","amount":0.065379,"announcedDate":"2024-08-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-12","defaultRemindTime":1726147800000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-18","payableDate":"2024-09-12","currency":"USD","dateTimestamp":1726113600000,"payDate":"2024-10-18"},{"date":"2024-09-11","symbol":"SBHMY","amount":0.076916,"announcedDate":"2024-08-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-11","defaultRemindTime":1726061400000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-18","payableDate":"2024-09-11","currency":"USD","dateTimestamp":1726027200000,"payDate":"2024-10-18"},{"date":"2024-06-12","symbol":"SBHMY","amount":0.076829,"announcedDate":"2024-05-29","type":"dividend","market":"US","newRecordDate":"2024-06-12","defaultRemindTime":1718199000000,"name":"中国生物制药ADR","recordDate":"2024-07-22","payableDate":"2024-06-12","currency":"USD","dateTimestamp":1718164800000,"payDate":"2024-07-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBHMY\",market:\"US\",,,undefined,":[{"executeDate":"2018-09-10","recordDate":"2018-09-11","paymentDate":"2018-10-15","value":0.040958,"currency":"USD"},{"executeDate":"2018-12-04","recordDate":"2018-12-05","paymentDate":"2019-01-07","value":0.041124,"currency":"USD"},{"executeDate":"2019-06-13","recordDate":"2019-06-14","paymentDate":"2019-07-19","value":0.040963,"currency":"USD"},{"executeDate":"2019-09-11","recordDate":"2019-09-12","paymentDate":"2019-10-15","value":0.040986,"currency":"USD"},{"executeDate":"2019-12-09","recordDate":"2019-12-10","paymentDate":"2020-01-13","value":0.041103,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBHMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5833,"hold":0.0417,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":24,"updateTime":1758686400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBHMY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617554669","title":"正大天晴与赛诺菲达成超15亿独家授权；诺和诺德MASH新适应症拟纳入优先审评；全球首款宫颈癌前病变无创治疗药物获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2617554669","media":"药财社","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617554669?lang=zh_cn&edition=fundamental","pubTime":"2026-03-05 18:59","pubTimestamp":1772708377,"startTime":"0","endTime":"0","summary":"2诺和诺德MASH新适应症拟纳入优先审评3月3日，国家药监局药品审评中心官网显示，诺和诺德旗下司美格鲁肽注射液新适应症在国内申请上市，并拟纳入优先审评。此前，该药物已于2025年8月获美国FDA批准。3全球首款宫颈癌前病变无创治疗药物获批上市3月3日晚间，亚虹医药发布公告，其核心产品APL-1702正式获得国家药监局批准上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305191315a44f9681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305191315a44f9681&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNY","BK4599","LU1093756325.SGD","SBHMY","IE00BKVL7J92.USD","01177","NVOH","BK4588","BK4585","IE00BZ1G4Q59.USD","BK4532","LU0154236417.USD","LU1093756168.USD","NVO","BK4007","NVOX"],"gpt_icon":1},{"id":"2616332509","title":"中国生物制药：集团自主研发的1类创新药罗伐昔替尼上市获得药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332509","media":"财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332509?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 17:26","pubTimestamp":1772443607,"startTime":"0","endTime":"0","summary":"近日，中国生物制药发布公告称，集团自主研发的国家1类创新药罗伐昔替尼片已获得中国国家药品监督管理局的上市批准，适用于中危-2或高危的原发性骨髓纤维化、真性红细胞增多症后骨髓纤维化或原发性血小板增多症后骨髓纤维化成年患者的一线治疗。在一项多中心、随机、双盲、双模拟、阳性药物平行对照的II期临床研究中，罗伐昔替尼对比羟基尿在治疗中危-2、高危骨髓纤维化患者中展示出优异的疗效和良好的安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302173018a731073c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302173018a731073c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMF","SBHMY","BK4007"],"gpt_icon":0},{"id":"2616533268","title":"同类首创引领骨髓纤维化治疗新时代，正大天晴罗伐昔替尼获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533268","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616533268?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 16:27","pubTimestamp":1772440050,"startTime":"0","endTime":"0","summary":"此次罗伐昔替尼获批是基于一项随机、双盲、阳性对照2期关键研究。其次，抗纤维化与疾病修饰将成为药物研发的核心目标，下一代治疗药物将更加注重降低基因突变负荷、逆转骨髓纤维化进程、延长患者总生存期，而罗伐昔替尼的ROCK抑制机制恰好契合这一研发方向，具备天然的研发优势。总结全球MF靶向治疗已从JAK单靶点迈入多靶点协同时代，正大天晴罗伐昔替尼片以全球首创JAK/ROCK双重抑制剂的身份，为中高危MF患者带来革命性治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030216463297a7a138&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030216463297a7a138&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SBHMY","PMF"],"gpt_icon":0},{"id":"2613636877","title":"【券商聚焦】中泰国际指港股受地缘政治影响，科技与资源股表现分化","url":"https://stock-news.laohu8.com/highlight/detail?id=2613636877","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613636877?lang=zh_cn&edition=fundamental","pubTime":"2026-02-24 11:03","pubTimestamp":1771902192,"startTime":"0","endTime":"0","summary":"金吾财讯|中泰国际发布研报指，前一交易日港股在缺乏南向资金下仍强势上涨，恒生指数升2.5%收报27,081点，恒生科技指数涨3.3%报5,385点。地缘政治紧张推动国际金价突破5,100美元，带动资源股普涨，紫金矿业及灵宝黄金分别升5.3%和6.2%。AI板块显著回调，智谱因产品问题股价暴跌22.8%。美股受地缘风险拖累全线下跌，道琼斯指数跌1.6%，市场避险情绪升温。宏观层面，国内春节旅游数据亮眼，飞猪平台国内游订单量创新高，高星级酒店人均预订量近3晚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224112242a4c12729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224112242a4c12729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MPNGY","LU3063872942.SGD","LU0130103400.USD","LU0203345920.USD","LU0359202008.SGD","SG9999015986.USD","01177","SGXZ90724238.SGD","BK1505","LU2051468812.USD","SG9999000327.SGD","LU1044874839.SGD","SG9999001226.SGD","LU0328353924.USD","BK1544","BK1575","SGXZ81514606.USD","LU0455707207.USD","LU0052750758.USD","LU0067412154.USD","IE00B031HY20.USD","LU0345776255.USD","LU0683595622.HKD","LU0254981946.USD","IE00B031J352.USD","LU1642822792.SGD","LU0143863198.USD","LU0588545730.USD","LU2362541513.USD","LU2293587155.HKD","LU1115378108.SGD","LU0164872284.USD","LU0572939691.SGD","LU0650527681.SGD","LU1366334651.USD","BK1502","LU0196878994.USD","LU1481107354.HKD","LU2125910849.SGD","LU1814569148.SGD","LU0531970944.HKD","LU0588545904.SGD","SG9999018857.SGD","BK1515","LU0326948709.USD","LU0878004406.USD","LU0784639295.USD","LU0327786744.USD","LU1785774172.SGD","BK1249","LU1064131003.USD","BK1594","LU0128522744.USD","LU0084288322.USD","LU0605514214.HKD","LU1548497426.USD","LU2125910500.SGD","LU1282649810.SGD","LU0516422440.USD","BK1095","LU0898667661.SGD","BK1592","LU0499858602.USD","LU0577902371.SGD","LU0501845795.SGD","LU0823413660.USD","LU1733274473.HKD","LU0642271901.SGD","SG9999014914.USD","BK1584","LU1316542783.SGD","LU0607220059.USD","IE00B8L5B284.USD","LU0164880469.USD","LU0456827905.SGD","HK0000320264.USD","LU1328615791.USD","LU0648000940.SGD","LU2279701549.SGD","LU0509642566.USD","LU1883866441.USD","LU1725190679.HKD","LU0823426480.USD","LU0873338254.USD","BK1618","LU0828237940.HKD","LU0080751232.USD","LU1515016050.SGD","LU0588545490.SGD","LU0463099449.HKD","SG9999007991.SGD","LU0441854154.USD","LU1880398471.USD","LU0823040885.USD","LU1226287529.USD","LU1282649141.HKD","IE00B067MR52.USD","LU2045819591.USD","LU0320764243.SGD","02899","LU0229945570.USD","LU0871576103.HKD","LU1720050803.USD","LU1810669033.SGD","IE0001KFT4U8.USD","IE0003895053.USD","LU0251144936.SGD","LU0620787316.HKD","LU0235996351.USD","LU2226246903.HKD","SG9999015945.SGD","LU2097828805.USD","LU1224444064.USD","LU0370786039.SGD","LU0572944931.SGD","LU1282649067.USD","LU0082770016.SGD","HK0000352382.USD","LU1282651121.HKD","LU0287142896.SGD","LU1303224171.USD","LU0348827113.USD","LU1224709979.USD","LU0011963245.USD","LU0456846285.SGD","LU0611395673.USD","HMTD.SI","LU0540923850.HKD","LU1733274390.USD","SG9999006514.SGD","LU0737861699.HKD","LU0348723411.USD","LU0384037296.USD","LU0651946864.USD","LU1831875114.USD","LU1993786604.SGD","LU2247934214.USD","SG9999018865.SGD","LU1718418525.SGD","LU0140636845.USD","LU2237443622.USD","LU2097828474.EUR","LU2462611646.USD","LU0868486357.SGD","SG9999001846.SGD","02595","LU0577902298.EUR","LU0047713382.USD","LU1720051108.HKD","09988","LU0348784397.USD","LU0516422366.SGD","LU1880383366.USD","LU0054450605.USD","LU0823038988.USD","LU1226288097.SGD","LU1023057109.AUD","LU2265009873.SGD","BK1609","IE0003851619.USD","LU0594300419.USD","IE0008369823.USD","LU2237443978.SGD","IE00BQXX3F31.USD","LU0823039010.USD","LU0543330483.HKD","LU1868837722.USD","SG9999014906.USD","LU0132412106.USD","LU0314109678.HKD","LU0345780281.USD","LU0049853897.USD","LU0543330566.HKD","LU0269904917.USD","LU0828237510.HKD","LU1044875133.USD","LU0163747925.USD","LU2362540622.SGD","LU0315179316.USD","LU0127658192.USD","LU0043850808.USD","LU2106854487.HKD","LU1951186391.HKD","LU1196710351.USD","LU0106252389.USD","ALBmain","LU0359201612.USD","LU0985320562.USD","LU1046422090.SGD","HK0000914686.HKD","LU0082770016.USD","LU0456854461.SGD","HK0000165453.HKD","LU2023250504.SGD","LU2097829019.USD","LU0972618739.USD","IE00B29SXG58.USD","HK0000352291.HKD","LU0348783233.USD","LU0738912210.USD","IE00B0JY6N72.USD","LU0791591158.USD","LU0289960550.SGD","BK1117","LU1226287875.USD","LU0329678170.USD","LU1568876335.HKD","LU0417516571.SGD","LU0797268264.HKD","LU2097828631.EUR","LU0572940350.SGD","LU0675040207.SGD","LU0828238088.HKD","HK0000306685.HKD","SG9999002828.SGD","LU2177674079.SGD","LU0700851271.USD","LU1105468828.SGD","BK1517","LU0143863784.USD","LU0791590937.USD","LU0049112450.USD","LU0181495838.USD","LU1629966141.USD","SG9999001069.SGD","SG9999014880.SGD","LU0577902538.SGD","LU2476274308.USD","LU0651947912.USD","LU1051769294.HKD","LU0762540952.USD","HBBD.SI","IE00BMPRXR70.SGD","LU2317271919.USD","LU0117844026.USD","LU0106259558.USD","LU0640798160.USD","LU1044876610.USD","LU0819121731.USD","LU1366334578.USD","IE00BQXX3D17.EUR","LU0593848301.USD","LU0577902454.USD","LU1282651048.USD","LU0072913022.USD","LU0819123356.HKD","LU0594300179.USD","601899","LU1008478684.HKD","IE00BZ08YR35.GBP","LU2498475776.HKD","IE0032431581.USD","LU0786609619.USD","00700","LU0165289439.USD","LU0737861772.HKD","LU0107464264.USD","LU0128522157.USD","IE00B031HW06.USD","METmain","LU0417516738.SGD","LU0348814723.USD","LU0051755006.USD","LU0499858438.USD","LU0516422952.EUR","LU0259732245.USD","LU1769817096.USD","SG9999004220.SGD","BK1198","LU0762542818.HKD","LU0823426308.USD","LU1226288253.USD","SG9999001093.SGD","LU0345769128.USD","LU0096374516.USD","LU1242518857.USD","LU2449936058.SGD","LU0307460666.USD","LU0541502299.USD","LU2237443895.HKD","LU0823397103.USD","BK1591","LU0048580855.USD","LU0862451837.USD","LU0823413587.USD","LU2237443382.USD","LU0072462343.USD","LU1201861165.SGD","LU0228367735.SGD","LU1917777945.USD","LU1048484197.HKD","LU1226287792.SGD","LU0054237671.USD","LU2257852520.SGD","LU2362541273.HKD","LU0293314216.USD","LU2237443549.SGD","LU0048597586.USD","LU0633140560.USD","IE00B3M56506.USD","LU2133065610.SGD","BK1583","GB00BDT5M118.USD","IE00B5MMRT66.SGD","LU0918141887.USD","LU0029874905.USD","LU0414403682.SGD","LU2251237306.USD","LU0541501648.USD","LU0469268626.HKD","LU0608807433.USD","LU1981816686.USD","LU0169518387.USD","LU1769817179.HKD","LU1675838814.USD","LU0821914370.USD","SG9999001689.USD","LU1770034418.SGD","LU0762541174.USD","LU2399975544.HKD","LU0345775950.USD","LU1439102457.SGD","LU0831093199.SGD","LU1880398554.USD","LU1974910355.USD","LU0149721374.USD","LU0396098781.USD","LU0348735423.USD","LU0890818403.SGD","LU0345780521.USD","TCEHY","89988","LU1196710864.SGD","LU0633140727.USD","LU1719994722.HKD","LU1102505929.USD","LU1807302812.USD","LU2488822045.USD","BK1531","LU0210527791.USD","LU0417516902.SGD","BK1521","LU1328277881.USD","LU0516423091.SGD","LU0431992006.USD","LU0214875030.USD","LU0029875118.USD","LU0488056044.USD","HTCD.SI","LU2778985437.USD","BABA","IE0008368411.USD","HK0000320223.HKD","LU0708995153.HKD","BK1588","LU0192582467.USD","BK1142","IE00B8HQ1Z84.USD","IE00BZ08YS42.EUR","BK1610","LU0449515922.USD","LU1282648689.USD","LU0348816934.USD","LU1152091754.HKD","LU0588546209.SGD","LU0326950275.SGD","IE0003795394.USD","LU0210526637.USD","BK1604","LU0264606111.USD","LU0823041008.USD","LU0456842615.SGD","LU1323998911.USD","LU0261950983.USD","IE0031814852.USD","LU0531971595.HKD","03330","BK1501","LU1196710195.USD","LU1102505762.USD","LU1235295612.USD","LU1794554557.SGD","LU0173614495.USD","SG9999000459.SGD","SGXZ86797644.SGD","SG9999017495.SGD","LU0061477393.USD","LU0261947096.USD","LU2152927971.USD","LU1152091168.USD","LU1961090484.USD","LU0708995583.HKD","SG9999014674.SGD","LU2357305700.SGD","LU1242518931.SGD","IE00BZ08YT58.USD","LU0880133367.SGD","LU1804176565.USD","LU1048596156.SGD","LU1808992512.USD","LU0070217475.USD","LU0608807946.USD","BK1516","IE00B543WZ88.USD","LU1880383440.USD","LU0882747503.HKD","LU0878005551.USD","LU1226288170.HKD","LU1688375341.USD","LU1868837565.USD","HK0000306701.USD","IE00B0169L03.USD","LU0348788117.USD","SG9999013353.USD","LU1868838027.USD","LU0320764755.SGD","LU0048388663.USD","SG9999001903.USD","SG9999006597.SGD","SG9999002463.SGD","LU0561508036.HKD","LU0320764599.SGD","LU1504937902.USD","BK1615","LU0577902611.USD","IE00B97KM107.HKD","LU0315178854.USD","LU1439103000.SGD","BK1608","LU2148510915.USD","LU0117841782.USD","LU0672654166.SGD","LU0865486749.SGD","BK1586","03690","LU0329678337.USD","LU1956131251.USD","IE0008368304.USD","LU0210533765.USD","LU1051768304.USD","SG9999003461.SGD","IE00BF5LJ272.USD","LU0164939612.USD","LU0149534421.HKD","LU0862451753.SGD","SG9999002562.SGD","IE00B0169N27.USD","LU1960683339.HKD","LU2251237488.HKD","LU0211977185.USD","LU0345769631.USD","LU0348783662.USD","SGXZ62798434.SGD","LU0203347892.USD","LU2097828714.EUR","BK1589","LU0634319403.HKD","LU0630378692.HKD","LU0449509016.USD","ZIJMY","LU0918141705.HKD","IE00BPRC5H50.USD","SGXZ31699556.SGD","IE0009570106.USD","LU1211504680.USD","LU0886674414.USD","LU0164865239.USD","LU0244354667.USD","IE00BQXX3C00.GBP","LU2087589342.USD","LU0630378429.USD","LU2008162690.USD","SG9999014898.SGD","LU0831103253.SGD","LU2476274720.SGD","LU2237443465.HKD","LU0188438112.USD","LU2097828557.USD","LU1064130708.USD","LU1188198961.HKD","LU0348805143.USD","BK1233","SG9999000418.SGD","LU1568876251.USD","LU0197773160.USD","LU0266512127.USD","LU0823397285.USD","LU0106959298.USD","BK1191","LU0856984785.SGD","LU0516423174.USD","LU0231483743.USD","LU0266512473.USD","LU0211331839.USD","LU0979878070.USD","SG9999015978.USD","SG9999001051.SGD","LU2039709279.SGD","LU1813983027.USD","IE00BMPRXN33.USD","IE0032834883.USD","LU0359201885.HKD","IE0034224299.USD","LU0130518102.USD","LU0648948544.HKD","LU1251922891.USD","LU2242644610.SGD","LU0477156797.USD","HK0000914660.USD","BK1161","LU0197773673.USD","LU0502904849.HKD","LU0348825331.USD","LU1770036033.HKD","IE00BGV7N243.SGD","BK1526","SGXZ99366536.SGD","LU0039217434.USD","LU0589944569.HKD","TCHmain","LU0228659784.USD","LU1655091459.SGD","SGXZ51526630.SGD","LU0175139822.USD","LU1734074674.USD","IE0008368742.USD","SBHMY","LU1048588211.SGD","LU1720051017.SGD","SG9999015952.SGD"],"gpt_icon":1},{"id":"2610419995","title":"政府伙29间大型企业 为香港青年提供海内外暑期实习机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2610419995","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610419995?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 09:13","pubTimestamp":1770858780,"startTime":"0","endTime":"0","summary":"政府与29间大型企业合作推出民青局企业内地与海外暑期实习计划2026，为香港青年提供内地和海外暑期实习机会，企业包括腾讯、中华煤气、中银香港、恒隆地产及中国生物制药等。实习岗位遍布中国内地多个省市，包括多个粤港澳大湾区内地城市、北京、上海、成都、重庆及杭州等；海外国家则包括印尼、马来西亚、菲律宾、新加坡、泰国及澳洲等。沽空资料截至 2026-02-11 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220802134615382_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220802134615382_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1502838/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1502838/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1527","LU0320764243.SGD","LU0955648018.USD","LU2237443382.USD","LU0287142896.SGD","LU0289960550.SGD","SG9999015978.USD","82388","LU1725190679.HKD","LU0577902371.SGD","LU1951186391.HKD","LU1105468828.SGD","LU0047713382.USD","LU2106854487.HKD","LU1974910355.USD","LU0516423174.USD","LU1323998911.USD","LU0593848301.USD","LU2362541273.HKD","LU0886674414.USD","IE0003895053.USD","LU2476274308.USD","LU0828237510.HKD","LU1282651048.USD","SG9999007991.SGD","LU0132412106.USD","LU0633140727.USD","LU1046422090.SGD","LU0821914370.USD","HK0000914660.USD","LU0499858602.USD","LU1439102457.SGD","LU1316542783.SGD","LU0054237671.USD","LU3063872942.SGD","LU1688375341.USD","LU0441854154.USD","LU2237443549.SGD","LU0096374516.USD","LU1522347837.USD","LU0029875118.USD","LU1064131003.USD","LU1804176565.USD","LU0708995153.HKD","BK1191","LU1242518857.USD","LU1655091459.SGD","LU1439103000.SGD","LU1634259391.SGD","LU0784639295.USD","LU0228659784.USD","LU0048597586.USD","IE00BZ08YT58.USD","TCEHY","LU0972618739.USD","SG9999006597.SGD","IE00BQXX3F31.USD","LU1152091168.USD","LU0106252389.USD","LU0675040207.SGD","SG9999004220.SGD","00700","IE0008369823.USD","LU1734074674.USD","SG9999001903.USD","LU1226288253.USD","LU0588545730.USD","SGXZ81514606.USD","LU2362540622.SGD","IE00BZ08YR35.GBP","LU1769817179.HKD","LU0823426480.USD","LU0345769631.USD","LU0683595622.HKD","LU2251237306.USD","LU0577902611.USD","LU0261947096.USD","LU1497734951.SGD","LU2251237488.HKD","LU0588546209.SGD","LU0819123356.HKD","LU0648948544.HKD","SG9999013353.USD","LU1883866441.USD","LU1733274390.USD","LU0985320562.USD","BK1517","LU0293314216.USD","LU0231483743.USD","LU1102505762.USD","LU1023057109.AUD","LU1282648689.USD","LU2039709279.SGD","IE0034224299.USD","LU0572944931.SGD","LU0463099449.HKD","LU0211331839.USD","LU1917777945.USD","IE0032431581.USD","LU2051468812.USD","LU0738912210.USD","BK1516","LU2265009873.SGD","HTCD.SI","IE00BGHQDM52.EUR","LU0196878994.USD","HK0000352382.USD","LU1770034418.SGD","LU1196710351.USD","LU1808992512.USD","LU1242518931.SGD","BK1618","LU2008162690.USD","LU2663582299.SGD","LU0049112450.USD","LU1226287792.SGD","LU1044874839.SGD","LU0181495838.USD","LU2087589342.USD","LU0173614495.USD","LU2237443895.HKD","SG9999006514.SGD","LU1226288097.SGD","00101","LU0345776255.USD","IE00B031HY20.USD","LU0070217475.USD","LU0320764755.SGD","LU1880383366.USD","LU0561508036.HKD","LU0605514214.HKD","LU1993786604.SGD","BK1526","LU0235996351.USD","LU1769817096.USD","LU0329678337.USD","LU0786609619.USD","LU1048588211.SGD","BK1221","LU1226288170.HKD","LU0175139822.USD","LU0264606111.USD","00003","LU0608807946.USD","LU2097828557.USD","SG9999014914.USD","LU1008478684.HKD","LU2023250504.SGD","IE0009570106.USD","LU1044876610.USD","LU0261950983.USD","LU0192582467.USD","IE0008368411.USD","LU1960683339.HKD","IE00B5MMRT66.SGD","IE0031814852.USD","IE00B031HW06.USD","LU0501845795.SGD","LU2133065610.SGD","LU0543330566.HKD","LU1568876335.HKD","LU2293587155.HKD","SG9999015952.SGD","LU0384037296.USD","LU0048388663.USD","LU0823040885.USD","IE00B067MR52.USD","LU0214875030.USD","IE00BQXX3D17.EUR","LU0502904849.HKD","LU0370786039.SGD","LU0823426308.USD","LU0880133367.SGD","LU1196710195.USD","LU0862451837.USD","IE00B0JY6N72.USD","LU2257852520.SGD","IE00BGV7N243.SGD","LU0163747925.USD","SG9999014906.USD","LU0051755006.USD","LU0359201612.USD","LU0868486357.SGD","BK1555","LU0823413587.USD","LU0359202008.SGD","LU0828238088.HKD","LU0955623706.USD","LU2237443622.USD","LU0127658192.USD","LU0348788117.USD","SG9999001093.SGD","SGXZ51526630.SGD","LU0228367735.SGD","LU0819121731.USD","LU1868838027.USD","SG9999001069.SGD","LU0210526637.USD","LU0359201885.HKD","01177","LU0203345920.USD","BK1515","LU0572939691.SGD","LU1328277881.USD","IE00BVYPNQ40.USD","IE00B8HQ1Z84.USD","LU0509642566.USD","SG9999000459.SGD","LU0417516902.SGD","LU0307460666.USD","LU1497733631.SGD","LU0823397285.USD","LU0414403682.SGD","LU0589944569.HKD","LU0203347892.USD","BK1586","LU0229945570.USD","TCHmain","LU0140636845.USD","BK1095","LU0516422952.EUR","LU0577902298.EUR","LU0823397103.USD","SG9999001689.USD","LU0164865239.USD","LU0188438112.USD","LU0169518387.USD","LU0244354667.USD","LU1794554557.SGD","SG9999014674.SGD","LU2317271919.USD","03145","LU0080751232.USD","LU0314109678.HKD","LU0210533765.USD","SBHMY","LU1282649067.USD","LU0067412154.USD","LU1675838814.USD","LU0164880469.USD","IE0003851619.USD","LU1064130708.USD","LU2152927971.USD","LU1051768304.USD","LU0348827113.USD","LU0918141705.HKD","GB00BDT5M118.USD","LU0823038988.USD","LU1048484197.HKD","LU0572940350.SGD","LU0011963245.USD","LU1634259557.SGD","LU1497733557.USD","LU1868837722.USD","HLPPY","LU0541502299.USD","LU2399975544.HKD","LU0633140560.USD","LU0516422366.SGD","SG9999001846.SGD","LU2242644610.SGD","03143","LU0348805143.USD","LU1366334651.USD","LU0049853897.USD","LU1568876251.USD","LU0329678170.USD","LU0791590937.USD","LU0878005551.USD","LU1720050803.USD","LU0541501648.USD","LU0348814723.USD","LU0259732245.USD","LU0117844026.USD","LU2247934214.USD","LU1807302812.USD","BK1507","LU0455707207.USD","LU0700851271.USD","SG9999018865.SGD","LU0737861699.HKD","LU2778985437.USD","LU1051769294.HKD","LU1211504680.USD","LU0588545904.SGD","LU2125910849.SGD","LU0345769128.USD","LU0862451753.SGD","HK0000352291.HKD","LU1226287529.USD","SG9999015986.USD","LU0516423091.SGD","HOKCY","LU0540923850.HKD","LU0531970944.HKD","LU1196710864.SGD","LU1366334578.USD","LU0348783662.USD","LU2097828714.EUR","LU0456827905.SGD","LU2362541513.USD","BK1591","SG9999018857.SGD","LU1813983027.USD","LU0029874905.USD","LU0449515922.USD","IE00BF5LJ272.USD","LU1188198961.HKD","LU0634319403.HKD","LU0320764599.SGD","LU1130305938.SGD","SGXZ31699556.SGD","LU1235295612.USD","LU0737861772.HKD","SG9999000418.SGD","LU0328353924.USD","IE00BZ08YS42.EUR","LU1328615791.USD","SG9999000327.SGD","LU0348783233.USD","LU0642271901.SGD","02388","HK0000165453.HKD","LU0149721374.USD","LU1481107354.HKD","IE00B8L5B284.USD","BK1560","LU0611395673.USD","LU2045819591.USD","LU2237443465.HKD","LU1629966141.USD","LU0254981946.USD","BK1615","LU0231459107.USD","LU2498475776.HKD","IE00B0169L03.USD","LU0054450605.USD","LU0117841782.USD","LU0882747503.HKD","LU0594300179.USD","LU0588545490.SGD","BK1608","LU0128522157.USD","LU0345775950.USD","LU0797268264.HKD","LU2097828631.EUR","HK0000914686.HKD","LU2097828474.EUR","LU0348723411.USD","LU0417516738.SGD","LU0269904917.USD","LU0608807433.USD","LU0348825331.USD","LU1282649141.HKD","LU0918141887.USD","SG9999015945.SGD","LU1814569148.SGD","LU1226287875.USD","LU1303224171.USD","SG9999014898.SGD","LU0890818403.SGD","LU0878004406.USD","LU0831103253.SGD","LU0873338254.USD","LU1224709979.USD","SGXZ99366536.SGD","BK1609","LU1719994722.HKD","LU0456846285.SGD","LU0594300419.USD","IE00B29SXG58.USD","LU0128522744.USD","LU0048580855.USD","LU0898667661.SGD","LU0823413660.USD","SG9999002828.SGD","LU1152091754.HKD","BK1610","SG9999002463.SGD","LU0396098781.USD","LU0106259558.USD","IE0001KFT4U8.USD","LU1642822792.SGD","IE00BQXX3C00.GBP","LU0348735423.USD","SGXZ90724238.SGD","IE00B543WZ88.USD","LU2097828805.USD","LU2279701549.SGD","LU0431992006.USD","LU0043850808.USD","LU0210527791.USD","LU2177674079.SGD","LU0955669360.SGD","LU1251922891.USD","LU1048596156.SGD","LU1224444064.USD","LU0516422440.USD","LU0651946864.USD","IE00B97KM107.HKD","LU0499858438.USD","SG9999002562.SGD","LU0449509016.USD","IE00B031J352.USD","LU0143863198.USD","HK0000306685.HKD","LU0143863784.USD","LU0211977185.USD","LU0531971595.HKD","LU0823039010.USD","LU1961090484.USD","BK1531","IE0008368742.USD","LU0791591158.USD","BK1521","SG9999001226.SGD","LU0052750758.USD","BK1502","HK0000320223.HKD","LU1785774172.SGD","BK1229","SG9999003461.SGD","LU0149534421.HKD","LU0164872284.USD","SG9999001051.SGD","LU2462611646.USD","LU2237443978.SGD","LU1504937902.USD","IE00BPRC5H50.USD","LU0651947912.USD","LU0543330483.HKD","LU2476274720.SGD","LU0039217434.USD","LU1044875133.USD","LU1282651121.HKD","BK1577","LU1880383440.USD","LU0979878070.USD","LU0708995583.HKD","IE0032834883.USD","LU1770036033.HKD","LU2148510915.USD","LU1102505929.USD","BK1572","LU1733274473.HKD","IE00B0169N27.USD","HK0000306701.USD","LU2449936058.SGD","LU1718418525.SGD","LU1981816686.USD","BHKLY","LU0828237940.HKD","BK1231","LU0106959298.USD","BK1589","LU0072913022.USD","LU0650527681.SGD","BK1601","LU0315178854.USD","IE0003795394.USD","LU2125910500.SGD","LU0488056044.USD","LU0577902454.USD","LU0577902538.SGD","LU0107464264.USD","LU1515016050.SGD","LU0865486749.SGD","LU0327786744.USD","SG9999017495.SGD","LU0469268626.HKD","BK1258","LU0348816934.USD","LU0165289439.USD","LU0326950275.SGD","LU1956131251.USD","IE00B3M56506.USD","LU1282649810.SGD","LU0823041008.USD","LU1831875114.USD","LU2226246903.HKD","LU0672654166.SGD","LU0072462343.USD","LU0061477393.USD","LU0856984785.SGD","SG9999014880.SGD","LU1810669033.SGD","LU0348784397.USD","LU0456842615.SGD","LU0417516571.SGD","LU1508157978.USD","HK0000320264.USD","LU0084288322.USD","LU0607220059.USD","LU0251144936.SGD","LU0871576103.HKD","LU1868837565.USD","IE00BVYPNP33.GBP","LU0326948709.USD"],"gpt_icon":0},{"id":"2610921266","title":"港股指数早盘冲高回落 恒指半日升0.54 受压居前 新东方(09901)跌4.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610921266","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610921266?lang=zh_cn&edition=fundamental","pubTime":"2026-02-10 12:29","pubTimestamp":1770697766,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股指数早盘冲高回落，截至午间收盘，恒指升0.54%，恒科指升0.84%，国企指升0.78%。据灯塔专业版，截至2月9日20时，2026春节档新片预售总票房已突破7000万元。三大航集体受压，中国国航跌4.89%，中国东航跌4.14%，中国南航跌2.95%。此外，Kling的典型视频生成时间约 86.4 秒，快于 Sora 2 Pro的449.6秒。该机构表示，预计快手在2025年四季度总营收及调整后净利润将分别实现增长，KlingAI收入可能继续超预期增长。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974861","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03690","00960","09901","LU0048580855.USD","LGFRY","LU1023057109.AUD","LU0502904849.HKD","MPNGY","02269","BK4526","LU0359201612.USD","LU1969619763.USD","LU0164865239.USD","LU0370786039.SGD","BK1556","BK4563","LU2242644610.SGD","00027","LU0327786744.USD","SG9999002950.SGD","BK4503","BK4588","LU2517655291.USD","BK4204","BK4506","LU0605514214.HKD","LU0039217434.USD","SG9999001093.SGD","IE0034224299.USD","LU0307460666.USD","LU0588546209.SGD","BK1519","SG9999006597.SGD","HHImain","LU0871576103.HKD","WXXWY","BK4531","513600","HSCEI","HSTECH","09992","BK4535","PMRTY","06862","01177","BK4509","HSI","MCHmain","LU0594300419.USD","LU2517655374.HKD","BK4614","BK4585","BK1588","SBHMY","SG9999001069.SGD","LU0531971595.HKD","LU0823426308.USD","LU0594300179.USD","LU0572944931.SGD","LU0455707207.USD","SG9999001051.SGD","EDU","BK4510","01801","BK1596","02833","LU0650527681.SGD","LU0359202008.SGD","01093","BK1228","LU0823426480.USD","LU2517655028.SGD","LU2328871848.SGD","BK4505"],"gpt_icon":0},{"id":"2606203862","title":"医药生物行业周报：并购与授权合作持续活跃，关注创新药领域资源整合加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2606203862","media":"上海证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606203862?lang=zh_cn&edition=fundamental","pubTime":"2026-01-27 12:06","pubTimestamp":1769486783,"startTime":"0","endTime":"0","summary":"主要观点近期多起大额交易凸显创新药领域资源整合加速。通过此次收购，中国生物制药将获得siRNA赛道领先的自主技术平台、多元化产品管线及专业研发团队，丰富在大慢病领域的管线布局。目前，荣昌生物正在中国开展RC148单药及联合疗法治疗多种晚期恶性实体瘤患者的临床研究。投资建议我们认为，近期创新药领域并购与授权合作将持续活跃，中国创新药资产的全球认可度正在显著上升，资源整合加速，推动全球化布局与差异化发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127120632a6b14341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127120632a6b14341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","BK4007","02268","01875"],"gpt_icon":0},{"id":"2606016224","title":"中国生物制药慢乙肝1类新药Ⅱ期临床达主要终点，为低病毒血症提供新方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2606016224","media":"正大制药订阅号","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606016224?lang=zh_cn&edition=fundamental","pubTime":"2026-01-27 07:01","pubTimestamp":1769468467,"startTime":"0","endTime":"0","summary":"近日，中国生物制药核心企业正大天晴宣布，其针对慢性乙型肝炎病毒感染的口服1类新药——核心蛋白变构调节剂TQA3605在Ⅱ期临床研究中达到主要研究终点。临床现有抗病毒药物如核苷（酸）类药物可以有效抑制HBV复制，但部分患者仍存在应答不佳及低病毒血症，危害不容忽视。此外，低病毒血症患者的疾病进展风险更高，肝细胞癌发生率是病毒完全抑制者的2-4倍甚至更高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012707062897a37ab8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012707062897a37ab8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1589","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD","SBHMY","BK1521","IE00BZ08YR35.GBP","01177","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2595360726","title":"25年恒指累涨近28%：中国宏桥暴涨203.72%居成份股榜首，近10只个股翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2595360726","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595360726?lang=zh_cn&edition=fundamental","pubTime":"2025-12-31 14:31","pubTimestamp":1767162708,"startTime":"0","endTime":"0","summary":"港股2025年行情收官，恒生指数累涨27.77%，创下自2017年以来最佳年度表现。恒指成份股中，中国宏桥暴涨203.72%居榜首，紫金矿业涨162.29%，中芯国际涨124.69%，翰森制药涨113.33%，泡泡玛特涨111.46%，信达生物涨108.33%，周大福涨100.16%，中国生物制药涨98.71%，京东健康涨97.51%，中国人寿涨96.60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231143205a6e452f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231143205a6e452f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","CJEWY","LU0307460666.USD","02628","LU1023057109.AUD","02833","LU1719994722.HKD","601628","LU1770034418.SGD","01801","MCHmain","LU0359202008.SGD","LU0469268626.HKD","BK1500","ZIJMY","LU0702159699.USD","LU0264606111.USD","LU0359201885.HKD","01177","LU0359201612.USD","HHImain","HSI","LU1166156734.SGD","LU1251922891.USD","513600","LU1303224171.USD","LU0173614495.USD","LU0572939691.SGD","01929","LU0588546209.SGD","688981","LU0287142896.SGD","LU0572940350.SGD","BK1175","BK1594","PMRTY","BK1592","LU1224709979.USD","SG9999001093.SGD","MHImain","03692","SBHMY","06618","LU0737861699.HKD","01378","601899"],"gpt_icon":0},{"id":"2594235936","title":"中国生物制药获副总裁兼执行董事谢炘增持100万股 每股作价约6.41港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594235936","media":"新浪网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594235936?lang=zh_cn&edition=fundamental","pubTime":"2025-12-25 08:18","pubTimestamp":1766621894,"startTime":"0","endTime":"0","summary":"热点栏目自选股数据中心行情中心资金流向模拟交易客户端香港联交所最新资料显示，12月24日，副总裁兼执行董事谢炘增持中国生物制药100万股，每股作价6.4068港元，总金额为640.68万港元。增持后最新持股数目约为3.61亿股，最新持股比例为1.92%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225102536a47593c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225102536a47593c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","BK4007"],"gpt_icon":0},{"id":"2594869802","title":"18款1类新药首次获批临床！中国生物制药2025年多领域创新破局，全球化研发体系再深化","url":"https://stock-news.laohu8.com/highlight/detail?id=2594869802","media":"正大制药订阅号","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594869802?lang=zh_cn&edition=fundamental","pubTime":"2025-12-25 07:02","pubTimestamp":1766617330,"startTime":"0","endTime":"0","summary":"临床前研究显示，TQB2101在多种ROR1阳性肿瘤模型中展现出抗肿瘤活性，且具有良好的安全性特征。2025年，中国生物制药共有3款PROTAC新药首次获得临床批准。非临床研究显示，TQB3201脱靶风险低、遗传毒性阴性、生殖毒性可逆，较目前在研同类产品活性更高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225070854a474e3cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225070854a474e3cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","BK1589","BK1515","BK1191","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","HK0000165453.HKD","SBHMY"],"gpt_icon":0},{"id":"2593804455","title":"热搜第一！“进口抗癌假药”1500元一盒，有效成分却为0","url":"https://stock-news.laohu8.com/highlight/detail?id=2593804455","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593804455?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 21:27","pubTimestamp":1766410055,"startTime":"0","endTime":"0","summary":"经检测发现，该版本药品中安罗替尼的含量为0，即“境外版”安罗替尼本质上是完全没有有效成分的假药。该药物在国内流通后，因下游层层加价，一般患者购买的价格在1500元左右一盒，每盒的药量是正版的三倍。公安机关将患者家属提供的剩余药品送至鉴定机构检测，鉴定结论和上述药企的结论一致，即该安罗替尼“仿制药”中未检出安罗替尼成分。由此，连云港市市场监督管理局认定，涉案相关药品可以认定为假药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230225a46afb02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230225a46afb02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","SBHMY","BK1191","BK1515","BK1521","HK0000165453.HKD","BK1589","01177"],"gpt_icon":0},{"id":"2590377896","title":"【券商聚焦】中州国际指恒指短期承压，关注医药及能源板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377896","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377896?lang=zh_cn&edition=fundamental","pubTime":"2025-12-10 11:30","pubTimestamp":1765337434,"startTime":"0","endTime":"0","summary":"金吾财讯|中州国际发布研报指，12月9日恒生指数收报25,434点，跌1.29%，成交2,102亿港元；国企指数跌1.62%至8,936点；恒生科技指数收跌1.90%报5,554点。美国9月CPI同比3.0%低于预期，美联储10月下调利率至3.75-4.00%区间。能源板块中，中国海洋石油第三季度营收1,049亿元人民币，当前市盈率7.71倍低于10年平均33.34倍，股息收益率6.38%。地缘政治及美联储政策仍将影响港股表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210115012a72ec76d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210115012a72ec76d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02833","513600","02269","01177","HSCEI","HHImain","BK1161","00883","MHImain","SBHMY","600938","MCHmain","HSTECH","WXXWY","BK1574","BK1515","HSI"],"gpt_icon":1},{"id":"2589829615","title":"脱发新药III期成功；创新药出海新模式诞生","url":"https://stock-news.laohu8.com/highlight/detail?id=2589829615","media":"药创新","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589829615?lang=zh_cn&edition=fundamental","pubTime":"2025-12-06 17:01","pubTimestamp":1765011660,"startTime":"0","endTime":"0","summary":"科伦博泰与Crescent达成“双向授权”交易，中国创新药出海再添新玩法；雄激素脱发新药III期临床成功，预计明年申报上市；中国药品价格登记系统上线，面向企业和全球开放查询；默克中国宣布重要任命；FDA再现人事动荡……若Crescent近期发生控制权变更或与第三方签订分许可协议，科伦博泰亦有资格向Crescent收取额外款项。阅读详情>>研发动态雄激素脱发新药III期成功12月4日，Cosmo Pharmaceuticals宣布，Clascoterone用于治疗男性雄激素性脱发的两项关键III期试验中取得积极结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206170552a437ab11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206170552a437ab11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","III","BK4134","BK4007"],"gpt_icon":0},{"id":"2579462065","title":"利好密集来袭！创新药概念大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2579462065","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579462065?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:54","pubTimestamp":1761904444,"startTime":"0","endTime":"0","summary":"据证券时报报道，今年国家医保谈判在延续医保目录常规调整机制的基础上，首次正式引入“商保创新药目录”机制。此外，年内国产创新药“出海”进程明显提速。根据医药魔方NextPharma数据库，截至10月21日，中国创新药今年对外许可共发生115起，金额总计达到1012.4亿美元，远超2024年全年的519亿美元。国信证券指出，中国创新药产业已经体现出长期向好的发展趋势，并在近年集中体现在BD交易的爆发式增长。配置上，看好创新药长期逻辑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180526a47fc459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180526a47fc459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02552","SBHMY","06990","01952","BK4007","03759","09995"],"gpt_icon":0},{"id":"2579245144","title":"2025年西药行业市场发展现状趋势分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2579245144","media":"中研网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579245144?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:39","pubTimestamp":1761903584,"startTime":"0","endTime":"0","summary":"2025年西药行业市场发展现状趋势分析在人口老龄化加速、医疗技术革新与政策红利的三重驱动下，中国西药行业正经历从“规模扩张”到“质量跃升”的关键转型。据中研产业研究院《2025-2030年中国西药行业竞争分析及发展前景预测报告》分析二、西药产业链及市场规模1. 上游：原料药国产化与CDMO崛起原料药是西药产业的基石。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","SBHMY","BK1583","01276","BK1574","LU0320764599.SGD","06160","09969","03692","BK1576","01093","01801","06978","09995","02359","LU0052750758.USD","LU2045819591.USD","02196","BK1141","BK1161","LU0708995583.HKD","LU2242644610.SGD","01177","LU2125910500.SGD"],"gpt_icon":0},{"id":"2579167282","title":"中国生物制药又一款 1 类新药首次启动临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2579167282","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579167282?lang=zh_cn&edition=fundamental","pubTime":"2025-10-30 14:12","pubTimestamp":1761804767,"startTime":"0","endTime":"0","summary":"10 月 29 日，中国药物临床试验登记与信息公示平台显示，中国生物制药旗下泰德制药1 类新药注射用 TRD208 启动首个临床试验。截图来源：药物临床试验登记与信息公示平台TRD208 是一款非阿片类双模式长效镇痛1 类创新药，融合了神经传导阻滞和抗炎的双重机制，临床前数据显示其对于中度急性疼痛具有显著获益。9 月，该药在国内获批临床，默示许可适应症为成人术后镇痛，并于近日正式启动临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030141540a6d61d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030141540a6d61d5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1191","01177","BK1515","BK1589","IE00BZ08YS42.EUR","SBHMY","BK1521"],"gpt_icon":0},{"id":"2575288909","title":"中国生物制药(1177HK)：PDE3/4抑制剂II期临床数据亮眼 市场潜力巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=2575288909","media":"招银国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575288909?lang=zh_cn&edition=fundamental","pubTime":"2025-10-13 00:00","pubTimestamp":1760284800,"startTime":"0","endTime":"0","summary":"中国生物制药在欧洲呼吸学会2025 年会上公布了其PDE3/4 抑制剂TQC3721 的II 期临床结果，临床结果显示TQC3721 可快速改善患者肺功能和症状。临床数据表明TQC3721 具备同类最佳潜力。PDE3/4 药物市场潜力巨大，竞争格局良好。默沙东在今年7 月宣布以100 亿美元收购Verona，体现PDE3/4 抑制剂巨大的市场潜力。作为全球进度第二且唯一处在III 期临床的PDE3/4 抑制剂，我们认为TQC3721 具备重磅海外授权潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101310413494c5896a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101310413494c5896a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","BK4007"],"gpt_icon":0},{"id":"2571800933","title":"大健康行业周报 |13亿，“中国美敦力”完成交割；东星医疗：拟以支付现金方式购买武汉医佳宝90%的股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2571800933","media":"保观","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571800933?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 12:04","pubTimestamp":1759118650,"startTime":"0","endTime":"0","summary":"保观 |聚焦保险创新国内篇行业动态13亿，“中国美敦力”完成交割近日，上海生物医药并购基金携手浦东创投集团旗下引领区基金，完成收购日本大冢集团所持微创医疗股份的交割，交易金额达13亿元人民币，上海生物医药并购基金成为微创医疗重要战略股东，持股约7.3%。此次交割完成后，被视为“中国美敦力”的微创医疗股价在港股市场表现活跃，市值突破200亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929123929a44b6c21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929123929a44b6c21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0008369823.USD","BK1606","LU1152091168.USD","06160","BK1515","LU1993786604.SGD","IE00B5MMRT66.SGD","LU1226287792.SGD","BK1593","LU1226288253.USD","LU2543165471.USD","LU1008478684.HKD","01093","LU2039709279.SGD","BK1197","BK1570","LU0072913022.USD","IE0008368742.USD","LU0067412154.USD","LU1969619763.USD","00570","LU1226287875.USD","LU0315179316.USD","LU1719994722.HKD","00874","LU1960683339.HKD","IE00B543WZ88.USD","BK1500","LU0326950275.SGD","LU1251922891.USD","LU0588546209.SGD","01276","IE00B031HY20.USD","SBHMY","03320","BK1191","03692","03933","02196","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1023057109.AUD","LU1328277881.USD","LU1226287529.USD","01177","LU1152091754.HKD","LU2328871848.SGD","IE00BZ08YR35.GBP","LU0359201885.HKD","LU1226288170.HKD","LU1303224171.USD"],"gpt_icon":0},{"id":"2571782687","title":"华源证券-医药行业周报信立泰：全面布局CKM管线，创新出海加速推进-250928","url":"https://stock-news.laohu8.com/highlight/detail?id=2571782687","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571782687?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 23:02","pubTimestamp":1759071720,"startTime":"0","endTime":"0","summary":"全面布局CKM管线，创新出海加速推进。我们认为信立泰创新研发已经迎来重大蜕变，公司全面布局心血管-肾脏-代谢慢病领域，在研管线涵盖高血压、血脂异常、心衰、代谢、肾科等多个领域，并布局单抗、多抗、ADC、多肽、环肽、基因编辑等新型技术平台，多款产品已经进入到临床阶段，不断强化公司在中国慢病领域综合性龙头地位。我们看好信立泰基于心血管为核心的CKM创新管线布局，带动公司成长为中国综合性慢病领域创新药龙头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092900142997af3c80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092900142997af3c80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0067412154.USD","BK1515","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1226288253.USD","BK1191","LU2039709279.SGD","LU0359201885.HKD","BK1574","LU1226288170.HKD","LU1226287529.USD","LU0315179316.USD","LU1813983027.USD","IE00BZ08YS42.EUR","LU1152091168.USD","LU1226287792.SGD","LU1993786604.SGD","SBHMY","IE00BZ08YT58.USD","LU0359201612.USD","LU0501845795.SGD","01177","LU1951186391.HKD","LU1023057109.AUD","03692","LU0072913022.USD","LU0140636845.USD","BK1589","IE0008369823.USD","IE00B543WZ88.USD","BK1521","LU0359202008.SGD","LU0326950275.SGD","SG9999004220.SGD","BK1161","IE00B5MMRT66.SGD","09926","01093","LU0880133367.SGD","01276","LU1960683339.HKD","LU2543165471.USD","BK1583","IE0008368742.USD","LU1152091754.HKD","LU0314109678.HKD","LU1008478684.HKD","LU1226287875.USD","06978","LU1807302812.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}